(Press-News.org) The HIV epidemic is the largest in the world and represents one of the most serious public health problems, according to data from the World Health Organization (WHO). Only 30% of the more than 10 million patients in need have the access to the antiretroviral treatment. The total number of infected people exceeds 30 million and there are about 3 million new infections per year. The best hope for reducing the incidence of AIDS (Acquired Immune Deficiency Syndrome) is a preventive vaccine.
The most effective preventive vaccines act by inducing a response based on neutralizing antibodies. Some groups had shown that HIV-infected patients can produce a broad neutralizing response. But so far, all studies have excluded patients on antiretroviral therapy with undetectable viral load, i.e., having an improved profile compared to untreated patients.
To better understand the induction of neutralizing antibodies in these patients, researchers from IDIBAPS/Hospital Clinic of Barcelona, bound to the program HIVACAT (Research Project AIDS Vaccine), for the first time, have included samples of patients treated with a low level of viral replication. 508 samples were analyzed in 364 patients (191 treated and 173 with no antiretroviral treatment) through a new strategy based on the use of recombinant viruses.
The study represents the first big test and evaluation of the neutralization in HIV-infected persons with undetectable viral load. "We have shown that patients receiving antiretroviral treatment are able to induce a broad and strong humoral immune response (broad-spectrum neutralizing antibodies) for HIV despite having undetectable viremia", says the last author of the study, Eloisa Yuste. In these patients, the low level of antigenic stimulation may be compensated by an improved B cell function induced by antiretroviral treatment.
The report concludes that the percentage of treated and untreated patients that generated broad-spectrum neutralizing antibodies was very similar: 2.3%. This is the first step in identifying the epitope able to induce the development of these antibodies and therefore would be an excellent candidate for potential AIDS preventive vaccine based on the development of broad-spectrum neutralizing antibodies. This is how other highly effective preventive vaccines such as them against human papillomavirus, hepatitis A and B and polio, among others.
Neutralizing antibodies do not work when HIV infection is already established. But their presence induced by a vaccine could prevent infection if an uninfected person comes in contact with the virus. So, the next step is to get the induction of broad-spectrum neutralizing antibodies are generated in patients who have not acquired the virus. "The next stages of the research will characterize these broad-spectrum neutralizing antibodies and identify the virus that has led and could serve as a potential preventive vaccine in healthy people", she concludes.
###
About IDIBAPS
The Institut d'Biomedical Research August Pi i Sunyer (IDIBAPS) is a public entity of the Generalitat de Catalunya. Its main objective is to integrate quality clinical research with high-level basic research. So get a more effective transfer of scientific breakthroughs in the prevention and treatment of health problems more prevalent.
The IDIBAPS scientists are from the various entities that form Hospital Clinic of Barcelona, Faculty of Medicine, University of Barcelona, Institute for Biomedical Research of Barcelona from CSIC and the staff hired by the Fundació Clínic. IDIBAPS scientific production places it as the most productive biomedical center of Spain and as a reference for his leadership on major national and European projects.
Biomedicine behind these professionals is to minimize the barriers between the laboratory and medical appointments. IDIBAPS aims to facilitate the challenges of medicine is moving smoothly in basic research, and the results obtained in the laboratory is effectively reversed into benefits for patients. Improving the health of people is the ultimate goal.
About HIVACAT
The proposed research and vaccine development for AIDS, HIVACAT, is composed of two established research centers very important that there are currently over AIDS: the AIDS Research Institute IrsiCaixa Hospital Germans Trias i Pujol and Disease Service Infectious and AIDS of Hospital Clínic de Barcelona. HIVACAT research in developing new HIV vaccine in conjunction with ESTEVE and with the support of the Fundación La Caixa, the Department of Health and the Department of Economics and Knowledge of the Generalitat de Catalunya and the Fundació Clínic. The consortium represents the first significant experience of cooperation in this field between public authorities, researchers and business.
Both research centers develop along at 7.500 patients who benefit from the rapid introduction of new treatments developed at the same sites and gained international innovations. HIVACAT has a team of over 60 scientists trained in internationally renowned research centers such as Harvard University in the United States, the Pasteur Institute in Paris and the Royal Free Hospital in London.
In Spain, the project is co-chaired by Dr. Bonaventura Clotet, Hospital Germans Trias i Pujol and Dr. Josep Maria Gatell the Hospital Clinic. The scientific coordination is provided by the researcher IrsiCaixa ICREA research professor of Christian Brander.
A study opens the possibility of developing a preventive vaccine against HIV/AIDS
2011-05-23
ELSE PRESS RELEASES FROM THIS DATE:
USC research determines apparent genetic link to prostate cancer in African-American men
2011-05-23
Los Angeles, Calif., May 22, 2011—Some men of African descent may have a higher genetic risk of developing prostate cancer, according to research conducted at the Keck School of Medicine of the University of Southern California (USC).
The genome-wide association study, published in the journal Nature Genetics on May 22, determined a marker of risk for prostate cancer in men of African descent, who tend to more susceptible to prostate cancer than men of non-African descent. The research team was led by Christopher Haiman, ScD., at the USC Norris Comprehensive Cancer Center ...
Study of stem cell diseases advanced by new Stanford technique
2011-05-23
STANFORD, Calif. — A rare genetic disease called dyskeratosis congenita, caused by the rapid shortening of telomeres (protective caps on the ends of chromosomes), can be mimicked through the study of undifferentiated induced pluripotent stem cells, according to new findings from the Stanford University School of Medicine. Although dyskeratosis affects only about one in a million people, the scientists' findings could greatly facilitate research into this and other diseases caused by stem cell malfunctions, including some bone marrow failure syndromes and, perhaps, pulmonary ...
Mushroom compound suppresses prostate tumors
2011-05-23
A mushroom used in Asia for its medicinal benefits has been found to be 100 per cent effective in suppressing prostate tumour development in mice during early trials, new Queensland University of Technology (QUT) research shows.
The compound, polysaccharopeptide (PSP), which is extracted from the 'turkey tail' mushroom, was found to target prostate cancer stem cells and suppress tumour formation in mice, an article written by senior research fellow Dr Patrick Ling in the international scientific journal PLoS ONE said.
Dr Ling, from the Australian Prostate Cancer Research ...
BlackjackChamp Presents the Web's Only Free Tool to Instantly Match Any Mobile Device Model with Mobile Casinos
2011-05-23
BlackjackChamp.com is the leading all inclusive online gambling directory, as well as mobile gambling news and information portal. Blackjack Champ was established to help players find trustworthy and reputable businesses to play real money casino online games on the Internet.
For the past 8 years, Blackjack Champ earned the trust and loyalty of thousands of satisfied visitors. The Blackjack Champ brand is respected by both the gaming industry and mainstream media, which acknowledges us as mobile and online gambling industry experts.
During the past year, the mobile ...
New Stanford device could reduce surgical scarring
2011-05-23
STANFORD, Calif. — Researchers at Stanford University have developed a special wound dressing that they report was able to significantly reduce scar tissue caused by incisions.
Results of animal tests and of an early clinical trial of the dressing were "stunning," said Michael Longaker, MD, MBA, the Deane P. and Louise Mitchell Professor at the School of Medicine and senior author of a study that details the findings. "It was a surprisingly effective treatment."
The study will be published online May 23 in the Annals of Surgery.
After sutures are removed, the edges ...
Access to personal medical records increases satisfaction among new cancer patients
2011-05-23
A new analysis has found that allowing full access to personal medical records increases satisfaction without increasing anxiety in newly diagnosed cancer patients. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that providing accurate information to patients through medical records can be a beneficial complement to verbal communication with their physicians.
Most cancer patients say they are eager to receive comprehensive information about their disease, but many physicians believe that providing it increases ...
Fungi reduce need for fertilizer in agriculture
2011-05-23
NEW ORLEANS, LA – May 23, 2011 -- The next agricultural revolution may be sparked by fungi, helping to greatly increase food-production for the growing needs of the planet without the need for massive amounts of fertilizers according to research presented today at the 111th General Meeting of the American Society for Microbiology in New Orleans.
"The United Nations conservatively estimates that by the year 2050 the global human population is expected to reach over 9 billion. Feeding such a population represents an unprecedented challenge since this goes greatly beyond ...
Globalization exposes food supply to unsanitary practices
2011-05-23
NEW ORLEANS, LA – May 23, 2011 -- As the United States continues to import increasingly more of its food from developing nations, we are putting ourselves at greater risk of foodborne disease as many of these countries do not have the same sanitary standards for production, especially in the case of seafood and fresh produce, say scientists today at the 111th General Meeting of the American Society for Microbiology in New Orleans.
"Approximately 15 percent of food consumed in the United States in 2006 was imported. Sanitation practices for food production are not universally ...
CDC assesses potential human exposure to prion diseases
2011-05-23
Philadelphia, PA, May 23, 2011 – Researchers from the Centers for Disease Control and Prevention (CDC) have examined the potential for human exposure to prion diseases, looking at hunting, venison consumption, and travel to areas in which prion diseases have been reported in animals. Three prion diseases in particular – bovine spongiform encephalopathy (BSE or "Mad Cow Disease"), variant Creutzfeldt-Jakob disease (vCJD), and chronic wasting disease (CWD) – were specified in the investigation. The results of this investigation are published in the June issue of the Journal ...
$5000 Prize Leaderboard and $6000 Sponsorship Package on Offer from InterPoker and RakeTheRake.com
2011-05-23
Another week and another great promotion from RakeTheRake.com to celebrate its new site launch. There's $11,000 worth of prizes to be snapped up, provided by InterPoker and RakeTheRake. InterPoker's very special promotion is one of a wealth of amazing additional prizes running for three months until the end of July 2011. This three month period of extra special poker promotions is over and above the regular $500k+ of monthly promotions at RakeTheRake.
InterPoker has put together a great competition over the full three month period. Online poker players at the room have ...